文献速递创伤与烧伤重症综合管理与镇静镇痛

严重创伤后持续性代谢组学改变是慢性危重症的特征

Persistent metabolomic alterations characterize chronic critical illness after severe trauma.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论严重创伤后死亡或发生慢性危重症(CCI)的患者,伤后1天即可通过代谢组学区分,涉及炎症、氧化应激、氨基酸代谢和肠道菌群改变。

本研究对存活≥7天的严重创伤休克患者进行静脉血质谱代谢组学分析,比较死亡或发生CCI(ICU住院≥14天伴持续器官功能障碍)者与快速恢复者(ICU住院≤7天)及未受伤对照。共检测163种代谢物,56种代谢物和21条通路在结局组间存在差异,偏最小二乘判别分析模型最早在伤后1天即可区分结局组。差异涉及色氨酸、苯丙氨酸、酪氨酸代谢,甲硫氨酸氧化应激相关代谢物,炎症介质(犬尿氨酸、花生四烯酸、葡萄糖醛酸)及肠道菌群产物(吲哚-3-丙酸)。靶向代谢组学有潜力早期识别伤后代谢改变以改善诊断和靶向干预。

要点

  • 严重创伤休克存活≥7天患者中,死亡或CCI组27例 vs 快速恢复组33例,伤后1天偏最小二乘判别分析模型即可区分两组。
  • 163种检测代谢物中56种和21条通路在结局组间存在差异,涉及色氨酸、苯丙氨酸、酪氨酸代谢及甲硫氨酸相关氧化应激。
  • 炎症介质犬尿氨酸、花生四烯酸、葡萄糖醛酸及肠道菌群产物吲哚-3-丙酸在结局组间存在差异。
  • CCI定义为ICU住院≥14天伴持续器官功能障碍,快速恢复定义为ICU住院≤7天。
  • 证据等级为预后/流行病学III级,靶向代谢组学可能有助于早期诊断和靶向干预。

适用人群与场景

  • 严重创伤伴休克且存活至少7天的患者,静脉血样本用于代谢组学分析。
  • 比较组为死亡或发生CCI(ICU住院≥14天伴持续器官功能障碍)者、快速恢复者(ICU住院≤7天)及未受伤对照。
  • 研究纳入27例死亡或CCI患者和33例快速恢复患者,另设48例健康对照,年龄和性别分布相似。

诊断标准与关键阈值

  • CCI定义为ICU住院时间≥14天且伴持续器官功能障碍。
  • 快速恢复定义为ICU住院时间≤7天。
  • 原文未提及代谢物浓度具体阈值或评分界值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为预后/流行病学分析,样本量为27例死亡或CCI患者和33例快速恢复患者,另有48例健康对照;受试者65%为男性,中位年龄53岁,损伤严重度评分36。
  • 从163种检测代谢物中,56种代谢物和21条通路在创伤结局组间存在差异,偏最小二乘判别分析模型最早在伤后1天即可区分结局组。
  • 差异涉及色氨酸、苯丙氨酸和酪氨酸代谢;甲硫氨酸代谢相关氧化应激代谢物;炎症介质包括犬尿氨酸、花生四烯酸和葡萄糖醛酸;以及肠道菌群产物吲哚-3-丙酸。
  • 原文未提及关键次要终点和不良事件的具体数据。

证据类型、等级与局限

  • 证据类型为预后/流行病学观察性研究,证据等级为III级。
  • 原文未述局限性。

对床旁实践的改变

  • 靶向代谢组学有潜力在伤后早期(最早1天)识别严重创伤后死亡或CCI高风险的代谢改变,可能改善早期诊断和靶向干预。
  • 原文未提及对具体治疗方案的改变或适用/不适用人群的排除标准。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Following trauma, persistent inflammation, immunosuppression, and catabolism may characterize delayed recovery or failure to recover. Understanding the metabolic response associated with these adverse outcomes may facilitate earlier identification and intervention. We characterized the metabolic profiles of trauma victims who died or developed chronic critical illness (CCI) and hypothesized that differences would be evident within 1-week postinjury.

METHODS: Venous blood samples from trauma victims with shock who survived at least 7 days were analyzed using mass spectrometry. Subjects who died or developed CCI (intensive care unit length of stay of ≥14 days with persistent organ dysfunction) were compared with subjects who recovered rapidly (intensive care unit length of stay, ≤7 days) and uninjured controls. We used partial least squares discriminant analysis, t tests, linear mixed effects regression, and pathway enrichment analyses to make broad comparisons and identify differences in metabolite concentrations and pathways.

RESULTS: We identified 27 patients who died or developed CCI and 33 who recovered rapidly. Subjects were predominantly male (65%) with a median age of 53 years and Injury Severity Score of 36. Healthy controls (n = 48) had similar age and sex distributions. Overall, from the 163 metabolites detected in the samples, 56 metabolites and 21 pathways differed between injury outcome groups, and partial least squares discriminant analysis models distinguished injury outcome groups as early as 1-day postinjury. Differences were observed in tryptophan, phenylalanine, and tyrosine metabolism; metabolites associated with oxidative stress via methionine metabolism; inflammatory mediators including kynurenine, arachidonate, and glucuronic acid; and products of the gut microbiome including indole-3-propionate.

CONCLUSIONS: The metabolic profiles in subjects who ultimately die or develop CCI differ from those who have recovered. In particular, we have identified differences in markers of inflammation, oxidative stress, amino acid metabolism, and alterations in the gut microbiome. Targeted metabolomics has the potential to identify important metabolic changes postinjury to improve early diagnosis and targeted intervention.

LEVEL OF EVIDENCE: Prognostic/epidemiologic, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Horn DL, Bettcher LF, Navarro SL, et al. Persistent metabolomic alterations characterize chronic critical illness after severe trauma. J Trauma Acute Care Surg. 2021. PMID: 33017357. doi:10.1097/TA.0000000000002952

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。